The significance of elevated tumor markers among patients with interstitial lung diseases
Authors:
Open Access
- 6 October 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-7
Abstract
The clinical implication of using serum tumor markers in patients with interstitial lung disease (ILD) is inconclusive. In this retrospective study, we analyzed the data of 1176 subjects (294 with ILDs and 882 healthy controls). Eligible patients were who had at least one or more available tumor marker results [carbohydrate antigen (CA) 19-9, CA 125, and carcinoembryonic antigen (CEA)] with no evidence of malignancies or other benign diseases that could be related to the increasing concentration of the values. The healthy controls selected from a health screening program were also screened for the presence of active cancer, and matched at a ratio of 1:3 with age and sex. The proportion of patients with abnormal values in the ILD group (121, idiopathic pulmonary fibrosis (IPF); 173, non-IPF-ILDs) was higher than in the matched control group (CEA, 21.5% vs. 5.5%; CA 19-9, 27.9% vs. 4.0%; CA 125, 36.4% vs. 2.0%). In the multivariable analysis, higher CEA levels were associated with shorter survival after adjusting for age, sex, lung function, and ILD subtypes (hazard ratio: 2.323, 95% confidence interval: 1.271–4.248, P = 0.006). In subgroup analysis, CEA remained a prognostic factor in patients with non-IPF-ILDs, but not in those with IPF.Keywords
This publication has 39 references indexed in Scilit:
- Beyond malignancy: the role of carbohydrate antigen 125 in heart failureBiomarker Research, 2013
- The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified EpitheliumPLOS ONE, 2013
- Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosisRespirology, 2012
- Should a Colonoscopy be Recommended for Healthy Individuals with Increased Carcinoembryonic Antigen Levels? A Case–Control StudyDigestive Diseases and Sciences, 2011
- Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary FibrosisChest, 2010
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status reportAnnals of Oncology, 2009
- Interstitial lung disease guidelineThorax, 2008
- The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing CholangitisDigestive Diseases and Sciences, 2005
- Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigenCancer, 1990
- INCREASED CARCINOEMBRYONIC ANTIGEN IN HEAVY CIGARETTE SMOKERSThe Lancet, 1973